EU chemical agency gives first hazardous substance authorisation


The European Chemicals Agency (ECHA) has granted its first approval to use a substance of very high concern (SVHC). Rolls Royce applied to use the chemical bis(2-ethylhexyl) phthalate (DEHP), which can cause central nervous system damage and birth defects, for the bonding of fan blades in jet engines.

SVHCs have been defined by the ECHA as those that cause irreversible damage to human health or the environment. If a chemical is put on this list it is the first step towards having its use restricted under the EU’s registration, evaluation, authorisation and restriction of chemicals (Reach) regulations.

The ECHA came to the conclusion that Rolls Royce’s plans to control exposure to DEHP were adequate. The final decision by the European commission will be based on the ECHA’s recommendations, which will be revisited in seven years time.


Related Content

Dangerous delivery problems dog chemical transport in China

26 February 2014 News and Analysis

news image

Lethal accident caused by contamination of parcels by toxic chemical highlights difficulties faced by small firms

GM maize poised for approval in Europe

18 February 2014 News and Analysis

news image

European commission is also examining the feasibility of allowing nationwide bans on engineered crops

Most Read

Complex amines made easy (and cheap)

22 May 2015 Research

news image

Iron-catalysed cross-coupling brings together nitroarenes and olefins in a single step in boon for drug makers

Opiate-producing yeast raises spectre of 'home-brewed heroin'

18 May 2015 News and Analysis

news image

Warnings that completion of final steps in opiate biosynthesis could be a double-edged sword

Most Commented

The nuclear danger of iodine

20 May 2015 Comments

news image

It may not be an element you think of as problematic. But, as Mark Foreman explains, iodine causes very complicated problems ...

Opiate-producing yeast raises spectre of 'home-brewed heroin'

18 May 2015 News and Analysis

news image

Warnings that completion of final steps in opiate biosynthesis could be a double-edged sword